The Technion is one of the few institutions worldwide that brings together biology with the physical sciences and engineering, to translate research more quickly into clinical solutions. Distinguished Professors Ciechanover and Avram Hershko’s Nobel Prize-winning discovery led to the drug Velcade, for the treatment of multiple myeloma. Other Technion scientists have made great strides in identifying biomarkers for early cancer detection, combating drug-resistant tumors, and developing personalized medicine and targeted drug delivery. With the launch of the Technion Integrated Cancer Center in 2016, headed by Profs. Ciechanover and Ze'ev Ronai, its interdisciplinary research is sure to reach new heights.